Skip to content

Menu

RESET-RA Study
Insights
Press Releases

SCIENCE
THERAPY
COMPANY
CAREERS

Menu

Home
Science
Therapy
Company
Insights
- Press Releases
Careers
Contact
RESET-RA Study

Revolutionizing how autoimmune diseases are treated

Scientific publications

April 30, 2019

SetPoint Medical to Present at Bank of America Merrill Lynch Health Care Conference 2019

April 18, 2019

Pain Medicine News – Neuromodulation Shown Potentially Safe, Effective for Rheumatoid Arthritis

April 2, 2019

ODT Magazine – Tiny Bioelectronic Implant Eases the Pain of Rheumatoid Arthritis

March 8, 2019

MD Edge – Vagus nerve stimulation for rheumatology? Maybe

March 4, 2019

Harnessing the Inflammatory Reflex for the Treatment of Inflammation-Mediated Diseases

October 23, 2018

SetPoint Medical Announces Data Supporting Continued Clinical Development of its Bioelectronic Device for Treatment of Rheumatoid Arthritis (RA)

October 16, 2018

SetPoint Medical Completes Enrollment in U.S. Pilot Study Evaluating Bioelectronic Device for Treatment of Rheumatoid Arthritis

September 20, 2018

R&D Magazine– Biotech Device Could Treat Rheumatoid Arthritis Without the Side Effects

August 24, 2018

The Evolution of Bioelectronic Medicine

«‹ 3 4 5 6 ›»

CAUTION – Investigational device. Limited by United States law to investigational use.

designElement

© 2023 SetPoint Medical is a registered trademark of SetPoint Medical Corporation in the United States and other countries. By using this website you agree to our Privacy Policy.

DISCLAIMER:

The patient experience shared in this video represents a unique individual experience and does not provide any indication, guide, warranty or guarantee as to the response other people may have to these and related therapies. Responses can and do vary; the response other individuals have could be different, including no response at all. The SetPoint Medical device is an investigational device. Its use is limited by United States law to investigational use. It is not approved for commercial use.